ARB-treated women have higher risk of new-onset diabetes

04/22/2012 | Diabetes.co.uk (U.K.)

Hypertensive women who were prescribed angiotensin receptor blockers were 93% more likely to develop new-onset diabetes compared with those who received angiotensin-converting-enzyme inhibitors, a study in the Journal of Clinical Hypertension revealed. More study is needed, but the findings may aid in decision-making among clinicians, the lead researcher said.

View Full Article in:

Diabetes.co.uk (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR